111 related articles for article (PubMed ID: 26133942)
41. A population-based study of the usefulness of screening for neuroblastoma.
Woods WG; Tuchman M; Robison LL; Bernstein M; Leclerc JM; Brisson LC; Brossard J; Hill G; Shuster J; Luepker R; Byrne T; Weitzman S; Bunin G; Lemieux B
Lancet; 1996 Dec 21-28; 348(9043):1682-7. PubMed ID: 8973429
[TBL] [Abstract][Full Text] [Related]
42. Histopathology defines prognostic subsets of ganglioneuroblastoma, nodular.
Umehara S; Nakagawa A; Matthay KK; Lukens JN; Seeger RC; Stram DO; Gerbing RB; Shimada H
Cancer; 2000 Sep; 89(5):1150-61. PubMed ID: 10964346
[TBL] [Abstract][Full Text] [Related]
43. Neuroblastoma incidence and survival in European children (1978-1997): report from the Automated Childhood Cancer Information System project.
Spix C; Pastore G; Sankila R; Stiller CA; Steliarova-Foucher E
Eur J Cancer; 2006 Sep; 42(13):2081-91. PubMed ID: 16919772
[TBL] [Abstract][Full Text] [Related]
44. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW
J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691
[TBL] [Abstract][Full Text] [Related]
45. Increased incidence rates but no space-time clustering of childhood astrocytoma in Sweden, 1973-1992: a population-based study of pediatric brain tumors.
Hjalmars U; Kulldorff M; Wahlqvist Y; Lannering B
Cancer; 1999 May; 85(9):2077-90. PubMed ID: 10223251
[TBL] [Abstract][Full Text] [Related]
46. [Time trends and pathological characteristics of thyroid cancer in urban Beijing, 1995 - 2010].
Yang L; Sun TT; Yuan YN; Wang N
Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Feb; 47(2):109-12. PubMed ID: 23719099
[TBL] [Abstract][Full Text] [Related]
47. Diffusion-weighted MRI for differentiation of neuroblastoma and ganglioneuroblastoma/ganglioneuroma.
Gahr N; Darge K; Hahn G; Kreher BW; von Buiren M; Uhl M
Eur J Radiol; 2011 Sep; 79(3):443-6. PubMed ID: 20462716
[TBL] [Abstract][Full Text] [Related]
48. International neuroblastoma pathology classification adds independent prognostic information beyond the prognostic contribution of age.
Sano H; Bonadio J; Gerbing RB; London WB; Matthay KK; Lukens JN; Shimada H
Eur J Cancer; 2006 May; 42(8):1113-9. PubMed ID: 16624549
[TBL] [Abstract][Full Text] [Related]
49. Surgical treatment of malignant mediastinal neurogenic tumors in children.
Kang CH; Kim YT; Jeon SH; Sung SW; Kim JH
Eur J Cardiothorac Surg; 2007 Apr; 31(4):725-30. PubMed ID: 17306984
[TBL] [Abstract][Full Text] [Related]
50. Magnetic resonance imaging of neuroblastoma, ganglioneuroblastoma, and ganglioneuroma.
Wang YM; Li YW; Sheih CP; Hsu JC
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1995; 36(6):420-4. PubMed ID: 8592928
[TBL] [Abstract][Full Text] [Related]
51. Tumors of the neuroblastoma group.
Shimada H
Pathology (Phila); 1993; 2(1):43-59. PubMed ID: 9420930
[TBL] [Abstract][Full Text] [Related]
52. Trends in cancer incidence among children in the U.S.
Gurney JG; Davis S; Severson RK; Fang JY; Ross JA; Robison LL
Cancer; 1996 Aug; 78(3):532-41. PubMed ID: 8697401
[TBL] [Abstract][Full Text] [Related]
53. The incidence and mortality rates of neuroblastoma cases before and after the cessation of the mass screening program in Japan: A descriptive study.
Shinagawa T; Kitamura T; Katanoda K; Matsuda T; Ito Y; Sobue T
Int J Cancer; 2017 Feb; 140(3):618-625. PubMed ID: 27778323
[TBL] [Abstract][Full Text] [Related]
54. Infant cancer in the U.S.: histology-specific incidence and trends, 1973 to 1992.
Gurney JG; Ross JA; Wall DA; Bleyer WA; Severson RK; Robison LL
J Pediatr Hematol Oncol; 1997; 19(5):428-32. PubMed ID: 9329464
[TBL] [Abstract][Full Text] [Related]
55. Descriptive epidemiology of selected olfactory tumors.
Villano JL; Bressler L; Propp JM; Valyi-Nagy T; Martin IK; Dolecek TA; McCarthy BJ
J Neurooncol; 2010 Oct; 100(1):73-80. PubMed ID: 20151173
[TBL] [Abstract][Full Text] [Related]
56. Trends in intracranial meningioma incidence in the United States, 2004-2015.
Lin DD; Lin JL; Deng XY; Li W; Li DD; Yin B; Lin J; Zhang N; Sheng HS
Cancer Med; 2019 Oct; 8(14):6458-6467. PubMed ID: 31475482
[TBL] [Abstract][Full Text] [Related]
57. Trends in childhood brain tumor incidence, 1973-2009.
McKean-Cowdin R; Razavi P; Barrington-Trimis J; Baldwin RT; Asgharzadeh S; Cockburn M; Tihan T; Preston-Martin S
J Neurooncol; 2013 Nov; 115(2):153-60. PubMed ID: 23925828
[TBL] [Abstract][Full Text] [Related]
58. The effect of age distribution on the prognosis of retroperitoneal neuroblastoma.
Liu X; Zhao J; Zhang L; Huang J; Ma Y
Medicine (Baltimore); 2020 Jun; 99(23):e20639. PubMed ID: 32502048
[TBL] [Abstract][Full Text] [Related]
59. Incidence of Horner syndrome associated with neuroblastic disease.
Kuchalska K; Barełkowska M; Derwich K; Jończyk-Potoczna K; Gotz-Więckowska A
Childs Nerv Syst; 2021 Apr; 37(4):1243-1247. PubMed ID: 33174155
[TBL] [Abstract][Full Text] [Related]
60. Comparison of Clinical Features and Outcomes in Patients With Bilateral Versus Unilateral Adrenal Neuroblastoma.
Dinh T; Truong B; Matthay KK; DuBois SG
J Pediatr Hematol Oncol; 2017 Mar; 39(2):108-113. PubMed ID: 27820129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
